Portfolio news 0

Oxford Nanopore Technologies Plc

Oxford Nanopore and A.D.A.M. Innovations announce international collaboration to accelerate advanced genomic medicine in Japan

Akamis Bio

Akamis Bio to Present Initial Data from the Phase 1b FORTRESS Study of NG-350A in Mismatch Repair-Proficient Locally Advanced Rectal Cancer at AACR 2026

Quantum Dice

Quantum Dice and NATS to collaborate on exploring probabilistic computing for Air Traffic Management

OXCCU

OXCCU joins UK consortium to help accelerate adoption of low carbon medicines manufacturing

Oxa

Oxa raises $103m in Series D first close, backed by National Wealth Fund and leading investors

Accelercomm Ltd

AccelerComm and Radisys Expand Satellite 5G Capabilities to Power Global IoT and Broadband Services

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies plc - Annual results for the year ended 31 December 2025

Artios Pharma

Artios Reports Randomized Phase 2a Study of Low Dose Alnodesertib Plus Gemcitabine Achieves Primary Endpoint in Platinum-Resistant Ovarian Cancer

First Light Fusion Ltd

First Light Fusion and Locai Labs announce research collaboration to broaden the application of AI in fusion energy research

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies plc - Update on legal action against MGI Australia Pty Ltd., in the Federal Court of Australia